scoliosis
Conditions
Interventions
Conventional Temperature Management Group:No pre-warming will be applied to the patient before anesthesia induction. The operating room temperature will be maintained at 22°C according to clinical sta
Experimental Group, Active Warming Group:In Group B, in addition to the measures used in Group A, an inflatable warming device will be applied. The specific procedure includes using the IOB-WU-505 + I
Sponsors
The First Affiliated Hospital of Harbin Medical University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: ? Undergoing elective scoliosis correction surgery; ? ASA classification of 1-3; ? Signed informed consent form; ? All procedures performed under general anesthesia with endotracheal intubation.
Exclusion criteria
Exclusion criteria: ? Patients undergoing growth rod expansion surgery; ? Patients who refuse allogeneic blood product transfusion; ? Critically ill condition (NYHA functional class > III or LVEF IV, or expected survival < 24 hours); ? Patients with severe coagulation disorders (including any of the following: congenital coagulation factor deficiency, PT or APTT prolonged more than 1.5 times the normal value, hereditary or acquired thrombocytopenia or platelet dysfunction).
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Intraoperative Blood Loss in Scoliosis Correction Surgery Patients Under Different Temperature Protection Measures;Coagulation Indicators in Postoperative Scoliosis Correction Surgery Patients Under Different Temperature Protection Measures; | — |
Secondary
| Measure | Time frame |
|---|---|
| Postoperative coagulation indicators (results of blood routine and coagulation function tests on the third postoperative day);Perioperative Hidden Blood Loss;Perioperative Transfusion of Blood Products;Incidence of perioperative hypothermia and occurrence of postoperative shivering;Postoperative adverse events (surgery-related complications; wound infection, etc.);Transfusion-related complications (ICU admission; death; respiratory, circulatory, digestive, urinary, and nervous system complications); | — |
Countries
China
Contacts
Public ContactKun Wang
The First Affiliated Hospital of Harbin Medical University
Outcome results
None listed